Company news

Avenue Therapeutics, Inc. (OTC:ATXI) news

Avenue Therapeutics, Inc. news releases on 6ix. Latest, Feb 23, 2026: Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04…

View Avenue Therapeutics, Inc. →

Press releases & updates

Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease

February 23, 2026

Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics

November 6, 2025